Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis
PLOS One · 2025
DOI: 10.1371/journal.pone.0337060 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yaqin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Mesenchymal Stem Cells, Umbilical Cord, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Shenzhen Biomedical Industry Major Public Service Platform and Core Technology Research Special Support Plan.
Abstract (Originalsprache)
Background
Autoimmune hepatitis (AIH) is a liver disease marked by immune-mediated hepatocyte damage. Current treatments have variable patient responses and considerable side effects, highlighting the need for alternative therapies. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have shown therapeutic potential in liver diseases, but their mechanisms in AIH remain unclear.
Methods
A Concanavalin A (ConA)-induced AIH-like mouse model was used to assess the therapeutic effects of hUC-MSCs. Survival, liver function-related serum marker expression, histopathology, and apoptosis were evaluated. Metabolomic profiling and ferroptosis-related markers were analyzed to uncover potential mechanisms.
Results
In ConA-induced AIH-like mouse model challenged with a lethal dose of ConA, hUC-MSC treatment significantly ameliorated liver tissue damage and serum liver function parameters, alleviated hepatocyte apoptosis, and improved survival. Metabolomic and ontology analyses of mouse liver tissue samples revealed that hUC-MSCs treatment altered the levels of metabolites (Glu derivatives and peptides) functionally associated with ferroptosis-related pathways. hUC-MSCs partially reversed ConA-induced malondialdehyde (MDA), oxidized glutathione (GSSG), glutamate, and Fe 2+ , while restoring reduced glutathione (GSH). Expression of COX2 was downregulated, whereas key ferroptosis suppressors, SLC7A11, GPX4, and FTH1, were upregulated following hUC-MSC treatment.
Conclusions
Based on the above evidence, we propose that hUC-MSCs may ameliorate ConA-induced liver injury in mice, potentially through modulation of ferroptosis-related pathways, and we support further investigation of hUC-MSCs as potential treatments for AIH. We believe that further in-depth studies are still needed to elaborate on the detailed regulatory mechanisms of MSCs on the ferroptosis pathway during the treatment of AIH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, People's Republic of China.
- Department of Infectious Disease, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
- Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
- Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
- Department of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, People's Republic of China.
ORCID-Profile: Wei V Zheng
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Shenzhen Biomedical Industry Major Public Service Platform and Core Technology Research Special Support Plan
- BYD Charity Foundation
- Medical Scientific Research Foundation of Guangdong Province
- Peking University Shenzhen Hospital Research Foundation
Zitieren
APA
Li, Y., Liu, B., Hu, G., Zhou, T., He, X., Guo, L., Zhang, L., Tong, W., Chen, Y., Xu, Y., Tong, G., & Zheng, W. V. (2025). Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis. PLOS One. https://doi.org/10.1371/journal.pone.0337060
Vancouver
Li Y, Liu B, Hu G, Zhou T, He X, Guo L, et al. Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis. PLOS One. 2025. doi:10.1371/journal.pone.0337060
BibTeX
@article{Li2025,
author = {Li, Yaqin and Liu, Bing and Hu, Guoxin and Zhou, Tao and He, Xuanqiu and Guo, Ling and Zhang, Luoshi and Tong, Weizhao and Chen, Yihua and Xu, Youhua and Tong, Guangdong and Zheng, Wei V},
title = {Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0337060}
}
EUVIMED